SS Innovations International, Inc. (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be prominently featured at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, highlighted in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in multiple sessions covering telesurgery, robotic surgery adoption, regulatory frameworks and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries and 225 pediatric surgeries, while approximately 2,100 physicians have been trained on the platform.
This announcement matters because it demonstrates the growing global adoption of SS Innovations’ technology, particularly in telesurgery, which could expand access to robotic surgery in underserved regions. The live broadcast of a remote partial nephrectomy from India to a conference in Florida underscores the potential for telemedicine to bridge geographic gaps in surgical care. Furthermore, the company’s focus on making robotic surgery affordable and accessible aligns with broader healthcare industry trends toward cost-effective, high-tech solutions.
The event also provides a platform for Dr. Srivastava to engage with peers on regulatory frameworks, which could influence policies that facilitate the adoption of robotic surgery worldwide. With over 2,100 physicians already trained on the SSi Mantra, the system is poised to play a significant role in shaping the future of surgical robotics. For industry observers, the company’s progress may signal a shift toward more accessible robotic platforms that challenge established players.
SS Innovations International develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. The company’s product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support a variety of procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.
For more information on the press release, visit https://ibn.fm/YYYKE.
